Dolsten Mikael

SEC CIK: 0001437590

SEC filings (opens in a new tab)

In the past year, 3 open-market sale filings worth $702.1K and no purchases.

Current role at each company

A Agilent Technologies, Inc.Directoras of Sep 9, 2026
RCKT Rocket Pharmaceuticals, Inc.Directoras of Jul 6, 2026
APLS Apellis Pharmaceuticals, Inc.Directoras of May 14, 2026
PFE Pfizer IncPresident R&Das of Sep 16, 2024

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $702.1K; 3 filings
Net: −$702.1K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Dolsten Mikael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

A Agilent Technologies, Inc.

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Sep 9, 2026 (view filing)4:01 PM ET	Sep 4	5 days	Dolsten MikaelDirector	SSale	−634	$151.38	−$96.0K	−11.4%4.92K after
Jun 2, 2026 (view filing)	May 29	4 days	Dolsten MikaelDirector	SSale	−1.60K	$135.42	−$216.7K	−22.4%5.55K after
Dec 3, 2025 (view filing)	Dec 1	2 days	Dolsten MikaelDirector	SSale	−2.60K	$149.81	−$389.5K	−34.3%4.97K after

PFE Pfizer Inc

President R&D2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 12, 2022 (view filing)	May 11	1 day	Dolsten MikaelPresident R&D	SSale	−63.9K	$49.32	−$3.15M	−16.1%333.3K after	6 lots
Nov 15, 2021 (view filing)	Nov 11	4 days	Dolsten MikaelPresident R&D	SSale	−59.7K	$50.29	−$3.00M	−17.6%279.8K after	7 lots